Abstract
VLDL levels are elevated in type II diabetes, where they contribute to the risk of coronary heart disease. A study by Wolfrum and Stoffel (2006) shows that the forkhead protein Foxa2 stimulates hepatic VLDL production in concert with the coactivator PGC-1β and that insulin inhibits this process by inactivating Foxa2.
Original language | English |
---|---|
Pages (from-to) | 449-450 |
Number of pages | 2 |
Journal | Molecular Cell |
Volume | 21 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2006 Feb 17 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology